NCT04891276View on ClinicalTrials.gov

Impact of COVID-19 Infection and Confinement on Diabetic Ulcer Management and Amputation Risk

CompletedOBSERVATIONAL
Enrollment

3,300,000

Participants

Timeline

Start Date

October 16, 2020

Primary Completion Date

April 14, 2021

Study Completion Date

April 14, 2021

Conditions
Diabetic Subjects With Hospital Stays
Interventions
OTHER

Data collection

Data collection on the national PMSI database

Trial Locations (1)

21000

Chu Dijon Bourogne, Dijon

All Listed Sponsors
lead

Centre Hospitalier Universitaire Dijon

OTHER

NCT04891276 - Impact of COVID-19 Infection and Confinement on Diabetic Ulcer Management and Amputation Risk | Biotech Hunter | Biotech Hunter